Looks like market is re-rating this lower, similar but opposite direction to how A2M was re-rated up the other month. If FY17 NPAT comes in around $60m, it's trading at ~PE26, so still not exactly cheap for a company whose profit has gone down 40% YoY.
Ann: Shareholder Briefing, page-53
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)